SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-005749
Filing Date
2016-11-14
Accepted
2016-11-14 14:58:06
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q entiabio10q093016.htm 10-Q 744098
2 EX-31.1 ex31-1.htm EX-31.1 11683
3 EX-31.2 ex31-2.htm EX-31.2 11810
4 EX-32.1 ex32-1.htm EX-32.1 3433
5 EX-32.2 ex32-2.htm EX-32.2 3479
12 image0.jpg GRAPHIC 113922
  Complete submission text file 0001185185-16-005749.txt   4486975

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ergo-20160930.xml EX-101.INS 874521
7 XBRL TAXONOMY EXTENSION SCHEMA ergo-20160930.xsd EX-101.SCH 50022
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ergo-20160930_cal.xml EX-101.CAL 32264
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ergo-20160930_def.xml EX-101.DEF 257666
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ergo-20160930_lab.xml EX-101.LAB 328448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ergo-20160930_pre.xml EX-101.PRE 259148
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 971-228-0709
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52864 | Film No.: 161993962
SIC: 2833 Medicinal Chemicals & Botanical Products